Literature DB >> 10211407

Quantification of sub-femtomole amounts of Alzheimer amyloid beta peptides.

A Potempska1, K Mack, P Mehta, K S Kim, D L Miller.   

Abstract

We evaluated methods for the quantitative Western blot analysis of A beta 1-40 and A beta 1-42. Both chromogenic and chemiluminescent detection methods gave similar sensitivities (0.15 fmol of A beta 1-40 and 0.3 fmol of A beta 1-42); however, the chromogenic method was more rapid, simpler, less expensive and gave fewer background problems; consequently, it yielded more reliable results. Adsorption to various types of laboratory plasticware can greatly interfere with the accurate measurement of A beta, but this can be prevented by the addition of SDS or bovine serum albumin. Among several methods for concentrating A beta from biological materials, immunoadsorption to Sepharose-bound antibodies was the most efficient. It yielded 50% recovery of 1 pM A beta 1-42 or A beta 1-40 and so was a suitable method to measure A beta levels in human plasma. Through combined immunoadsorption and Western blotting we could determine the amounts of A beta isoforms secreted from 1 x 10(6) cells after a culture period as short as 1 h. This eliminates the need to use radiolabelling or over-expression to study A beta precursor processing Bovine serum contains subnanomolar A beta levels, similar to those that reportedly stimulate cell proliferation. That cultured cells quickly secrete these levels of A beta suggests that the peptide might exert an autocrine effect.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10211407     DOI: 10.3109/13506129908993283

Source DB:  PubMed          Journal:  Amyloid        ISSN: 1350-6129            Impact factor:   7.141


  7 in total

1.  Aβ Plaques.

Authors:  Lary C Walker
Journal:  Free Neuropathol       Date:  2020-10-30

2.  Tauopathy with paired helical filaments in an aged chimpanzee.

Authors:  Rebecca F Rosen; Aaron S Farberg; Marla Gearing; Jeromy Dooyema; Patrick M Long; Daniel C Anderson; Jeremy Davis-Turak; Giovanni Coppola; Daniel H Geschwind; Jean-Francois Paré; Timothy Q Duong; William D Hopkins; Todd M Preuss; Lary C Walker
Journal:  J Comp Neurol       Date:  2008-07-20       Impact factor: 3.215

3.  Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss.

Authors:  Yuesong Gong; Lei Chang; Kirsten L Viola; Pascale N Lacor; Mary P Lambert; Caleb E Finch; Grant A Krafft; William L Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-18       Impact factor: 11.205

4.  Aftins increase amyloid-β42, lower amyloid-β38, and do not alter amyloid-β40 extracellular production in vitro: toward a chemical model of Alzheimer's disease?

Authors:  Arnaud Hochard; Nassima Oumata; Karima Bettayeb; Olfa Gloulou; Xavier Fant; Emilie Durieu; Nelly Buron; Mathieu Porceddu; Annie Borgne-Sanchez; Hervé Galons; Marc Flajolet; Laurent Meijer
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

5.  Intraneuronal Abeta immunoreactivity is not a predictor of brain amyloidosis-beta or neurofibrillary degeneration.

Authors:  Jerzy Wegiel; Izabela Kuchna; Krzysztof Nowicki; Janusz Frackowiak; Bozena Mazur-Kolecka; Humi Imaki; Jarek Wegiel; Pankaj D Mehta; Wayne P Silverman; Barry Reisberg; Mony Deleon; Thomas Wisniewski; Tuula Pirttilla; Harry Frey; Terho Lehtimäki; Tarmo Kivimäki; Frank E Visser; Wouter Kamphorst; Anna Potempska; David Bolton; Julia R Currie; David L Miller
Journal:  Acta Neuropathol       Date:  2007-01-20       Impact factor: 17.088

6.  The link between intraneuronal N-truncated amyloid-β peptide and oxidatively modified lipids in idiopathic autism and dup(15q11.2-q13)/autism.

Authors:  Janusz Frackowiak; Bozena Mazur-Kolecka; N Carolyn Schanen; W Ted Brown; Jerzy Wegiel
Journal:  Acta Neuropathol Commun       Date:  2013-09-16       Impact factor: 7.801

7.  Femtomole immunodetection of synthetic and endogenous amyloid-beta oligomers and its application to Alzheimer's disease drug candidate screening.

Authors:  Lei Chang; Lara Bakhos; Zhiqiang Wang; Duane L Venton; William L Klein
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 2.866

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.